Michael A. Panzara files SEC Form 4 disclosures for WAVE Life Sciences Ltd.. They have made 6 open-market trades across 1 company since 2017, most recently 2022-05-05.
CIK 0001679039
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| WVE | 125,817 | $454K |
Shares reported on the most recent Form 4, priced at the 2022-05-06 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| WVE | SELL · 10b5-1 | 2022-05-05 | 2022-05-06 | $1.72 | $29K | -25.9% | +10.6% | +41.8% |
| WVE | SELL | 2022-02-16 | 2022-02-18 | $2.31 | $24K | -18.4% | -17.4% | -56.7% |
| WVE | SELL · 10b5-1 | 2021-02-16 | 2021-02-18 | $10.57 | $31K | +6.3% | +4.6% | -33.1% |
| WVE | SELL · 10b5-1 | 2020-02-18 | 2020-02-20 | $7.85 | $23K | -15.3% | +4.8% | +15.8% |
| WVE | SELL | 2019-07-05 | 2019-07-09 | $26.91 | $153K | -13.8% | -18.9% | -29.1% |
| WVE | SELL | 2019-03-11 | 2019-03-11 | $48.00 | $336K | -8.1% | -29.2% | -49.0% |
| WVE | SELL | 2019-02-19 | 2019-02-21 | $36.84 | $135K | +22.1% | +8.8% | -32.4% |
| WVE | SELL · 10b5-1 | 2018-02-16 | 2018-02-21 | $52.10 | $27K | -3.4% | -21.8% | -16.4% |
| WVE | SELL | 2018-02-15 | 2018-02-20 | $50.00 | $938K | -8.4% | -22.6% | -17.7% |
| WVE | SELL | 2017-07-12 | 2017-07-13 | $16.67 | $247K | +21.7% | +3.0% | +40.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.